Scopus
🔓 Açık Erişim
The treatment outcome of childhood dysgerminoma
Genel Tip Dergisi · Eylül 2021
Makale Bilgileri
DergiGenel Tip Dergisi
Yayın TarihiEylül 2021
Cilt / Sayfa31 · 248-251
Scopus ID2-s2.0-105009247852
Erişim🔓 Açık Erişim
Özet
Objective: To review retrospectively the demographic and clinical features and treatment approaches of patients with ovarian dysgerminoma. Material and Methods: The files of pediatric patients diagnosed with ovarian dysgerminom between 2006-2020 at Selcuk University Faculty of Medicine, Department of Pediatric Oncology were reviewed retrospectively. Results: Ten patients with dysgerminoma were included in the study. The ages of the patients ranged from 8 to 17 years (median, 12.5 years). While the mass was unilateral in nine patients (90%), it was bilateral in one patient (10%). In all patients, complaints of application were abdominal swelling and abdominal pain. Ovarian torsion developed in one patient. Preoperative alpha-feto protein levels were within normal limits in seven patients, while hCG levels were high in all seven patients. The lactate dehydrogenase enzyme level was measured in five patients and was high in all. Five patients underwent primary surgery, and all of these patients were in stage I. Additional treatment was not given. Neoadjuan treatment was applied in three patients due to bilateral disease or common disease. The follow-up time of patients ranged from one year to 13 years (median, 5.5 years). The overall survival rate of the patients was 87.5%. Conclusion: Disgerminoma should be considered in rapidly developing intraabdominal masses especially in peripubertal girls and treatment planning should be done accordingly.
Yazarlar (4)
1
Buket Kara
2
Hilal Akbas
3
Ilhan Çiftci
4
Yavuz Koksal
Anahtar Kelimeler
children
dysgerminoma
ovary
Kurumlar
Selçuk Üniversitesi
Selçuklu Turkey
University of Health Sciences
Istanbul Turkey